Bladder Cancer
📧 Sign up to get email alerts when something new happens for Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing Olaparib in Patients With Advanced or Metastatic (Cancer That Has Spread) Bladder Cancer and Other Genitourinary Tumors With DNA-Repair Genetic Changes [Phase 2]
A Phase 2 clinical trial evaluating olaparib for advanced or metastatic bladder cancer and other genitourinary tumors with DNA-repair gene c…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing Tumors [Phase 2]
A Phase 2 clinical trial update for trastuzumab deruxtecan (Enhertu) in HER2-expressing tumors, including bladder, biliary tract, cervical, …
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: BladMetrix Urine Test for Monitoring Recurrence in Non-Muscle Invasive Bladder Cancer
This entry notes a clinical trial (NCT07511517) evaluating the BladMetrix urine test to monitor recurrence in non-muscle invasive bladder ca…
-
CLINICAL_TRIALS safety_alert · 2026-04-08Clinical Trial Update: Vascular Toxicities of Immune ChecKpoint Inhibitors : From Bed to Benchside [NA]
A clinical trial update outlining vascular toxicities observed with immune checkpoint inhibitors, highlighting safety signals and implicatio…
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
ESPERANZA is an external control arm study of trastuzumab deruxtecan (T-DXd) for patients with HER2 IHC3+ solid tumors, sponsored by AstraZe…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Study of Two Dosing Schedules of Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment for Metastatic Bladder Cancer [Phase 2]
Phase 2 trial evaluating two dosing schedules of atezolizumab in combination with gemcitabine and cisplatin as first-line therapy for metast…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Determinants of Bladder Cancer Recurrence Study (The DETER Study)
The DETER Study, sponsored by Memorial Sloan Kettering Cancer Center, investigates determinants of bladder cancer recurrence and is currentl…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors [Phase 1]
Pfizer's Phase 1 study PF-08046876 is recruiting adults with various advanced solid tumors to evaluate safety and dosing. The trial includes…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Bladder EpiCheck Product Development Study
This clinical trial update indicates that Nucleix Ltd.'s Bladder EpiCheck product development study is currently recruiting to evaluate its …
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Detecting CREPT in Urine for Bladder Cancer Diagnosis and Monitoring
A clinical trial is recruiting to evaluate measuring CREPT protein levels in urine as a noninvasive method to diagnose and monitor bladder c…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Treatment Of Metastatic Bladder Cancer at the Time Of Biochemical reLApse Following Radical Cystectomy [Phase 2]
A Phase 2 clinical trial evaluating treatment for metastatic bladder cancer at the time of biochemical relapse after radical cystectomy; the…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients [NA]
This clinical trial update reports on germline alterations of tumor susceptibility genes in New York cancer patients across multiple cancer …
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011) [Phase 2]
A Phase 2 study of Intismeran Autogene (V940) in combination with BCG for bladder cancer is currently recruiting, targeting non-muscle-invas…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Neoadjuvant Nivolumab With and Without Urelumab in Cisplatin-Ineligible or Chemotherapy-refusing Patients With Muscle-Invasive Urothelial Carcinoma of the Bladder [Phase 2]
Phase 2 trial evaluating nivolumab with and without urelumab in cisplatin-ineligible or chemotherapy-refusing patients with muscle-invasive …
-
CLINICAL_TRIALS trial_result · 2026-04-03Clinical Trial Update: Closed-System Bladder Irrigation to Reduce Urinary Tract Infections After Endoscopic Urologic Surgery (IRIS Trial) [NA]
The IRIS trial evaluating closed-system bladder irrigation to reduce postoperative urinary tract infections after endoscopic urologic surger…
-
CLINICAL_TRIALS withdrawal · 2026-04-02Clinical Trial Update: Safety and Efficacy of CG0070 Oncolytic Virus Regimen in Patients With High Grade Non-Muscle Invasive Bladder Cancer [Phase 2]
Phase 2 trial of CG0070 for high-grade non-muscle invasive bladder cancer has been withdrawn.
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue
This ClinicalTrials.gov entry describes the NCI-sponsored study NCT02379429, a trial focusing on care of urothelial cancer patients and pros…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy
Clinical trial update noting ongoing recruitment for a study evaluating AI-enabled blue light enhanced cystoscopy for detecting bladder canc…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers [Phase 1]
Phase 1 study of AB598 as monotherapy and in combination across multiple advanced cancers is ongoing, with status active but not recruiting.
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Outcomes of Definitive Radiotherapy for Bladder Cancer
A clinical trial (NCT07503795) led by Sohag University is investigating outcomes of definitive radiotherapy for bladder cancer; the study is…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Relevance of the Urine Bacterial Culture Performed Before TransUrethral Resection of the Bladder for Post-operative Febrile Urinary Tract Infections Prevention: a Non-inferiority Randomized Controlled Trial [NA]
This clinical trial update outlines a non-inferiority randomized study evaluating whether performing a urine bacterial culture before transu…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial [Phase 1, Phase 2]
The INVITE trial is investigating in-home intravesical chemotherapy for non-muscle invasive bladder cancer and is currently recruiting for P…
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: A Study to Determine if Mesh Placement During Bladder Surgery Can Reduce the Chances of Developing a Hernia [Phase 3]
A Phase 3 trial evaluating mesh placement during radical cystectomy to reduce post-operative hernias has completed.
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue [NA]
A Memorial Sloan Kettering Cancer Center trial evaluating radiation therapy for solid tumors that have metastasized to soft tissue. The stud…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Sacituzumab Govitecan, Preceding Radical Cystectomy, in Treating Patients With Muscle-invasive Bladder Cancer [Phase 2]
Phase 2 study evaluating sacituzumab govitecan as neoadjuvant therapy before radical cystectomy for muscle-invasive bladder cancer has compl…